Trial Profile
Study to Evaluate Safety, Efficacy of Botulinum Toxin Type A in Patients With Cervical Dystonia.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Torticollis
- Focus Therapeutic Use
- Sponsors Allergan
- 15 Mar 2012 This trial has been discontinued in Portugal.
- 15 Mar 2012 Additional location (Portugal) added as reported by European Clinical Trials Database.
- 15 Mar 2012 Actual end date changed from Dec 2009 to Apr 2010 as reported by European Clinical Trials Database.